Poseida News Center

Read media coverage on Poseida, find resources for the working press, and get insights from our executive leadership team on the next wave of cell and gene therapies.

Featured Content

Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products

Considering Manufacturing and Commercial Advantages,
Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products

Gene Online | November 10, 2021

Takeda broadens gene therapy scope, turns to Poseida for non-viral approach

Takeda broadens gene therapy scope, turns to Poseida for non-viral approach

MedCity News | October 12, 2021  

P-PSMA-101 Elicits Encouraging Responses in Metastatic Castration-Resistant Prostate Cancer

P-PSMA-101 Elicits Encouraging Responses in Metastatic Castration-Resistant Prostate Cancer

OncLive | September 1, 2021

Executive Perspectives

Executive Perspectives - Eric Ostertag

Poseida Therapeutics: Creating the Next Wave of Cell & Gene Therapies With the Capacity to Cure

By Eric Ostertag, M.D., Ph.D., Chief Executive Officer
Drug Development & Delivery | September 1, 2021

Cell and Gene Therapy

Cell and Gene Therapy: Seeking Clarity Amid the Chaos

By Mark Gergen, President and Chief Business Officer
LinkedIn | November 10, 2021

Executive Perspectives - Kerry Ingalls

Optimizing Manufacturing Processes to Develop Novel Cell and Gene Therapies

By Kerry Ingalls, Chief Operating Officer
Cell & Gene Therapy Insights (registration required) | June 7, 2021

Media Library

Usage rights & restrictions: These media assets are free for editorial broadcast, print, online and radio use. They are restricted for other purposes.
If you are a member of the working press and need a resource that is not available on this website, please e-mail your request to sthailing@poseida.com and we will make every effort to respond as soon as possible.

Corporate Images

Headshots

Logos

MENU